Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Autoimmune Diseases: full-pipeline trial registry
14 of 26 indexed Autoimmune Diseases trials are currently recruiting.
Corpus placement: #627 of 28,707 conditions by registered trial count.
26 US clinical trials · 14 currently recruiting · #627 of 28,707 conditions by registered trial count
Autoimmune Diseases: 26 US clinical trials tracked, 14 recruiting.
Autoimmune Diseases is the subject of 26 registered US clinical trials on ClinicalTrials.gov, 14 of them currently open to new participants. 4 are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most active sponsor is Dragonfly Research, running 1 of these trials.
Enrollment posture brief
Registry condition autoimmune-diseases
OPEN 14 | RECR 54% | LATE 4 | EARLY 5 | RANK #627 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Advanced Renal Cell Carcinoma (54% recruiting · 13 trials)
Autoimmune Diseases lists 14 open slots (54% of 26 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Autoimmune Diseases on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Autoimmune Diseases is recruiting above its size-band peers.
14 of 26 indexed trials (53.8%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Autoimmune Diseases trials is spread across many organizations.
Dragonfly Research accounts for 1 of 26 trials (3.8%). 26 distinct sponsors appear on at least one study for this condition label.
-
Typical Autoimmune Diseases enrolment sits around 131 participants.
Median target enrolment is 131 among the 26 trials that report a genuine target (sentinel values excluded). 12 of those (46.2%) plan for fewer than 100 participants.
-
Autoimmune Diseases splits between interventional and observational designs.
14 interventional and 12 observational studies make up this index (53.8% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
26 total, page 1 of 1
Collection and Distribution of Biospecimens for Novel Research Uses
iSpecimen
NCT03848962
Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
Thomas Advanced Medical
NCT04684602
IMPACT - AndHealth Autoimmune Research Registry
AndHealth
NCT05883371
Testimonials and Navigation in Rheumatology
University of Alabama at Birmingham
NCT06469788
Maternal Autoimmune Disease Research Alliance (MADRA) Registry
Duke University
NCT03276923
Biologics And Clinical Immunology Cohort at Sinai
Icahn School of Medicine at Mount Sinai
NCT04784364
Rheumatology Diet Study
University of Central Florida
NCT06339957
Ovarian Tissue Cryopreservation for Fertility Preservation
University of Pittsburgh
NCT05875155
Deciphering the Genetic Architecture of Autoimmune Diseases
National Human Genome Research Institute (NHGRI)
NCT06948110
A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease
TScan Therapeutics
NCT06587828
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
Arcellx
NCT06626919
VNS Prospective Neuromodulation of Immune and Gastrointestinal Systems
University of Louisville
NCT03953768
Use of Acthar Gel Single-Dose Pre-Filled SelfJectTM Injector in Patients With Moderate-Severe Keratitis and Autoimmune Disease
Toyos Clinic
NCT06964269
X-linked Moesin Associated Immunodeficiency
Institut National de la Santé Et de la Recherche Médicale, France
NCT06278337
A Trial of Academic Detailing to Promote Prescribing of Biosimilars
Brigham and Women's Hospital
NCT07221890
Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension
Cumberland Pharmaceuticals
NCT02682511
Immuno-Oncology Database and Bioregistry
UNC Lineberger Comprehensive Cancer Center
NCT04656873
Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA)
Janssen Biotech
NCT01004432
Day and Night Closed-loop in Young People With Type 1 Diabetes
Jaeb Center for Health Research
NCT02925299
A Study to Investigate the Effects of CBP-307 on the Heart Rate-corrected QT Interval (QTc) in Healthy Subjects
Connect Biopharma Australia Pty
NCT04818229
Phase III Study of a Topical Gel Formulation for Treatment and Prevention of Raynaud's Phenomenon
MediQuest Therapeutics
NCT00419419
Study of Silicone-Associated Connective Tissue Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
NCT00001330
Humoral and T-Cell Responses to COVID-19 Vaccination in Multiple Sclerosis Patients Treated With Ocrelizumab Treated With Ocrelizumab or Natalizumab
Dragonfly Research
NCT04837651
Photo-Protection Trial (NB-UVB vs. Placebo) in High-risk Hospitalized COVID-19 Patients
Cytokind
NCT04818970
Treatment of Childhood Onset Psychiatric Disorders With Intravenous Immunoglobulin (IVIg)
National Institute of Mental Health (NIMH)
NCT00001768
Use of Cross-linked Donor Corneas as Carriers for the Boston Keratoprosthesis
Joseph B. Ciolino, MD
NCT01582880
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 4 |
| Phase 2 | 1 |
| Phase 3 | 3 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Autoimmune Diseases records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Autoimmune Diseases trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Autoimmune Diseases page
26 registered trials, 14 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 14 Autoimmune Diseases trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Dragonfly Research sponsors the most Autoimmune Diseases trials on record, review their full trial history before evaluating a specific study. See Dragonfly Research's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Autoimmune Diseases condition card totals 26 registered trials; most-linked intervention Topical AmphiMatrix with nitroglycerin (MQX-503); top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.